124 related articles for article (PubMed ID: 18508629)
1. HPV-16 RNA processing.
Schwartz S
Front Biosci; 2008 May; 13():5880-91. PubMed ID: 18508629
[TBL] [Abstract][Full Text] [Related]
2. Eight nucleotide substitutions inhibit splicing to HPV-16 3'-splice site SA3358 and reduce the efficiency by which HPV-16 increases the life span of primary human keratinocytes.
Li X; Johansson C; Cardoso Palacios C; Mossberg A; Dhanjal S; Bergvall M; Schwartz S
PLoS One; 2013; 8(9):e72776. PubMed ID: 24039800
[TBL] [Abstract][Full Text] [Related]
3. Multiple ASF/SF2 sites in the human papillomavirus type 16 (HPV-16) E4-coding region promote splicing to the most commonly used 3'-splice site on the HPV-16 genome.
Somberg M; Schwartz S
J Virol; 2010 Aug; 84(16):8219-30. PubMed ID: 20519389
[TBL] [Abstract][Full Text] [Related]
4. Polypyrimidine tract binding protein induces human papillomavirus type 16 late gene expression by interfering with splicing inhibitory elements at the major late 5' splice site, SD3632.
Somberg M; Zhao X; Fröhlich M; Evander M; Schwartz S
J Virol; 2008 Apr; 82(7):3665-78. PubMed ID: 18216120
[TBL] [Abstract][Full Text] [Related]
5. hnRNP G prevents inclusion on the HPV16 L1 mRNAs of the central exon between splice sites SA3358 and SD3632.
Yu H; Gong L; Wu C; Nilsson K; Li-Wang X; Schwartz S
J Gen Virol; 2018 Mar; 99(3):328-343. PubMed ID: 29458523
[TBL] [Abstract][Full Text] [Related]
6. Identification of an hnRNP A1-dependent splicing silencer in the human papillomavirus type 16 L1 coding region that prevents premature expression of the late L1 gene.
Zhao X; Rush M; Schwartz S
J Virol; 2004 Oct; 78(20):10888-905. PubMed ID: 15452209
[TBL] [Abstract][Full Text] [Related]
7. A 57-nucleotide upstream early polyadenylation element in human papillomavirus type 16 interacts with hFip1, CstF-64, hnRNP C1/C2, and polypyrimidine tract binding protein.
Zhao X; Oberg D; Rush M; Fay J; Lambkin H; Schwartz S
J Virol; 2005 Apr; 79(7):4270-88. PubMed ID: 15767428
[TBL] [Abstract][Full Text] [Related]
8. Identification of a 17-nucleotide splicing enhancer in HPV-16 L1 that counteracts the effect of multiple hnRNP A1-binding splicing silencers.
Zhao X; Fay J; Lambkin H; Schwartz S
Virology; 2007 Dec; 369(2):351-63. PubMed ID: 17869320
[TBL] [Abstract][Full Text] [Related]
9. A splicing enhancer in the E4 coding region of human papillomavirus type 16 is required for early mRNA splicing and polyadenylation as well as inhibition of premature late gene expression.
Rush M; Zhao X; Schwartz S
J Virol; 2005 Sep; 79(18):12002-15. PubMed ID: 16140776
[TBL] [Abstract][Full Text] [Related]
10. Suppression of HPV-16 late L1 5'-splice site SD3632 by binding of hnRNP D proteins and hnRNP A2/B1 to upstream AUAGUA RNA motifs.
Li X; Johansson C; Glahder J; Mossberg AK; Schwartz S
Nucleic Acids Res; 2013 Dec; 41(22):10488-508. PubMed ID: 24013563
[TBL] [Abstract][Full Text] [Related]
11. Serine/Arginine-Rich Splicing Factor 3 and Heterogeneous Nuclear Ribonucleoprotein A1 Regulate Alternative RNA Splicing and Gene Expression of Human Papillomavirus 18 through Two Functionally Distinguishable cis Elements.
Ajiro M; Tang S; Doorbar J; Zheng ZM
J Virol; 2016 Oct; 90(20):9138-52. PubMed ID: 27489271
[TBL] [Abstract][Full Text] [Related]
12. Serine/arginine-rich protein 30c activates human papillomavirus type 16 L1 mRNA expression via a bimodal mechanism.
Somberg M; Li X; Johansson C; Orru B; Chang R; Rush M; Fay J; Ryan F; Schwartz S
J Gen Virol; 2011 Oct; 92(Pt 10):2411-2421. PubMed ID: 21697349
[TBL] [Abstract][Full Text] [Related]
13. Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35).
McFarlane M; MacDonald AI; Stevenson A; Graham SV
J Virol; 2015 May; 89(10):5276-87. PubMed ID: 25717103
[TBL] [Abstract][Full Text] [Related]
14. hnRNP L controls HPV16 RNA polyadenylation and splicing in an Akt kinase-dependent manner.
Kajitani N; Glahder J; Wu C; Yu H; Nilsson K; Schwartz S
Nucleic Acids Res; 2017 Sep; 45(16):9654-9678. PubMed ID: 28934469
[TBL] [Abstract][Full Text] [Related]
15. Role of Viral Ribonucleoproteins in Human Papillomavirus Type 16 Gene Expression.
Kajitani N; Schwartz S
Viruses; 2020 Sep; 12(10):. PubMed ID: 33007936
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneous Nuclear Ribonucleoprotein C Proteins Interact with the Human Papillomavirus Type 16 (HPV16) Early 3'-Untranslated Region and Alleviate Suppression of HPV16 Late L1 mRNA Splicing.
Dhanjal S; Kajitani N; Glahder J; Mossberg AK; Johansson C; Schwartz S
J Biol Chem; 2015 May; 290(21):13354-71. PubMed ID: 25878250
[TBL] [Abstract][Full Text] [Related]
17. Papillomavirus transcripts and posttranscriptional regulation.
Schwartz S
Virology; 2013 Oct; 445(1-2):187-96. PubMed ID: 23706315
[TBL] [Abstract][Full Text] [Related]
18. HPV-16 E2 contributes to induction of HPV-16 late gene expression by inhibiting early polyadenylation.
Johansson C; Somberg M; Li X; Backström Winquist E; Fay J; Ryan F; Pim D; Banks L; Schwartz S
EMBO J; 2012 May; 31(14):3212-27. PubMed ID: 22617423
[TBL] [Abstract][Full Text] [Related]
19. Adenovirus E4orf4 induces HPV-16 late L1 mRNA production.
Somberg M; Rush M; Fay J; Ryan F; Lambkin H; Akusjärvi G; Schwartz S
Virology; 2009 Jan; 383(2):279-90. PubMed ID: 19026433
[TBL] [Abstract][Full Text] [Related]
20. A downstream polyadenylation element in human papillomavirus type 16 L2 encodes multiple GGG motifs and interacts with hnRNP H.
Oberg D; Fay J; Lambkin H; Schwartz S
J Virol; 2005 Jul; 79(14):9254-69. PubMed ID: 15994820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
